Veru Inc. (VERU)
Nasdaq: VERU · Pharmaceutical Preparations · Miami, FL · filing with the SEC since 1996
Who owns Veru Inc.
As filed with the SECHolders of 5% or more
1
Alyeska Investment Group, L.P. holds 9.9% of Common Stock, $0.01 par value per share, as its SCHEDULE 13G filed Feb 17, 2026 says.
Directors and officers
8
report now, of 23 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Alyeska Investment Group, L.P.
SCHEDULE 13G · filed Feb 17, 2026 · Common Stock, $0.01 par value per share
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 12, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 16, 2025 · Common Stock · reported falling below 5%
What VERU reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 2 countries, from the list filed with the 10-K filed Dec 17, 2025.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 24 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Barnette K Gary | Chief Scientific Officer | 0 | $0 | 0 | 1 | $0 |